BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001
September 12, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 12, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Porch Group, Inc. Investor Alert: Robbins LLP is Investigating the Officers and Directors of PRCH on Behalf of Shareholders
September 07, 2023 14:46 ET
|
Robbins LLP
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Porch Group, Inc. (NASDAQ: PRCH) to determine whether certain Porch Group officers and...
eXp World Holdings Appoints Fred Reichheld to Board of Directors
September 07, 2023 12:30 ET
|
eXp World Holdings, Inc.
BELLINGHAM, Wash., Sept. 07, 2023 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (Nasdaq: EXPI) (the “Company”) this week announced the appointment of Net Promoter® System (NPS) creator Fred...
BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement
September 05, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
APLD Stock News: Investors with Significant Losses in Applied Digital Corporation Should Contact Robbins LLP About Recovery
August 28, 2023 17:30 ET
|
Robbins LLP
SAN DIEGO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Applied...
ALDX Stock News: Shareholders with Significant Losses in Aldeyra Therapeutics, Inc. Should Contact Robbins LLP
August 11, 2023 15:11 ET
|
Robbins LLP
SAN DIEGO, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased or otherwise acquired Aldeyra (NASDAQ: ALDX)...
BioCardia to Host Q2 2023 Financial Results and Corporate Update Conference Call on August 9, 2023
August 02, 2023 07:00 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
eXp World Holdings to Announce Second Quarter 2023 Results on August 3, 2023
July 26, 2023 08:30 ET
|
eXp World Holdings, Inc.
BELLINGHAM, Wash., July 26, 2023 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (Nasdaq: EXPI), the holding company for eXp Realty®, Virbela and SUCCESS® Enterprises, today announced it will report...
BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement
July 13, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 13, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives
June 27, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 27, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...